IMIPENEM ANHYDROUS, cilastatin, and RELEBACTAM ANHYDROUS
IMIPENEM ANHYDROUS, cilastatin, and RELEBACTAM ANHYDROUS · IMIPENEM ANHYDROUS 500 mg/100mL; CILASTATIN 500 mg/100mL; RELEBACTAM ANHYDROUS 250 mg/100mL · Injection, Powder, For Solution · Merck Sharp & Dohme LLC
NDC 00006-0138-01 · 221 VIAL, SINGLE-DOSE in 1 TRAY / 20 mL in 1 VIAL, SINGLE-DOSE · DRUG FOR FURTHER PROCESSING · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of IMIPENEM ANHYDROUS, cilastatin, and RELEBACTAM ANHYDROUS (Injection, Powder, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Merck Sharp & Dohme LLC | IMIPENEM ANHYDROUS 500 mg/100mL; CILASTATIN 500 mg/100mL; RELEBACTAM ANHYDROUS 250 mg/100mL | Jul 22, 2026 | Aug 28, 2026 |
| Merck Sharp & Dohme LLC | CILASTATIN 500 mg/100mL; IMIPENEM ANHYDROUS 500 mg/100mL; RELEBACTAM ANHYDROUS 250 mg/100mL | Jul 15, 2026 | Jul 18, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "IMIPENEM ANHYDROUS, cilastatin, and RELEBACTAM ANHYDROUS — NDC 00006-0138-01," retrieved September 3, 2026, https://drugdashboards.com/drug/00006013801.
Free to cite with attribution — see how the data is put together.